Isolated_incisional_metastases_after_intraperitoneal_radioactive_chromic_phosphate_therapy_for_ovarian_carcinoma._Two_women_developed_apparently_isolated_recurrences_of_ovarian_carcinoma_involving_prior_incisions_after_receiving_intraperitoneal_radioactive_chromic_phosphate_(P-32)_adjuvant_therapy_for_early_epithelial_ovarian_carcinoma._Both_are_alive_without_evidence_of_disease_at_second-look_laparotomy_after_surgical_resection_of_the_abdominal_wall_metastases_and_cisplatin-based_combination_chemotherapy._Mechanisms_of_cutaneous_and_incisional_implantation_metastases_are_discussed._Adjuvant_therapy_with_intraperitoneal_P-32_is_unable_to_provide_systemic_therapy_for_occult_metastatic_disease._The_favorable_outcome_in_these_cases_probably_reflects_limited_tumor_burden_at_the_time_of_recurrence_and_stands_in_stark_contrast_to_other_cases_of_soft_tissue_recurrences_of_ovarian_carcinoma_reported_previously.